1. Home
  2. ACOG vs LODE Comparison

ACOG vs LODE Comparison

Compare ACOG & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • LODE
  • Stock Information
  • Founded
  • ACOG 2000
  • LODE 2008
  • Country
  • ACOG Canada
  • LODE United States
  • Employees
  • ACOG N/A
  • LODE N/A
  • Industry
  • ACOG
  • LODE Major Chemicals
  • Sector
  • ACOG
  • LODE Industrials
  • Exchange
  • ACOG Nasdaq
  • LODE Nasdaq
  • Market Cap
  • ACOG 80.3M
  • LODE 53.0M
  • IPO Year
  • ACOG N/A
  • LODE N/A
  • Fundamental
  • Price
  • ACOG $10.69
  • LODE $3.81
  • Analyst Decision
  • ACOG Strong Buy
  • LODE Buy
  • Analyst Count
  • ACOG 1
  • LODE 1
  • Target Price
  • ACOG $20.00
  • LODE $26.00
  • AVG Volume (30 Days)
  • ACOG 67.3K
  • LODE 543.0K
  • Earning Date
  • ACOG 08-14-2025
  • LODE 08-07-2025
  • Dividend Yield
  • ACOG N/A
  • LODE N/A
  • EPS Growth
  • ACOG N/A
  • LODE N/A
  • EPS
  • ACOG N/A
  • LODE N/A
  • Revenue
  • ACOG $2,928,654.00
  • LODE $3,376,027.00
  • Revenue This Year
  • ACOG N/A
  • LODE $33.58
  • Revenue Next Year
  • ACOG N/A
  • LODE N/A
  • P/E Ratio
  • ACOG N/A
  • LODE N/A
  • Revenue Growth
  • ACOG N/A
  • LODE 102.20
  • 52 Week Low
  • ACOG $3.75
  • LODE $1.26
  • 52 Week High
  • ACOG $11.40
  • LODE $10.10
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • LODE 58.75
  • Support Level
  • ACOG N/A
  • LODE $3.54
  • Resistance Level
  • ACOG N/A
  • LODE $3.92
  • Average True Range (ATR)
  • ACOG 0.00
  • LODE 0.28
  • MACD
  • ACOG 0.00
  • LODE -0.04
  • Stochastic Oscillator
  • ACOG 0.00
  • LODE 47.62

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About LODE Comstock Inc.

Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.

Share on Social Networks: